Expression Profiling of Huntington's Disease Models Suggests That Brain-Derived Neurotrophic Factor Depletion Plays a Major Role in Striatal Degeneration
Authors:
- Andrew D. StrandASAndrew D. Strand
- Zachary C. BaquetZBZachary C. Baquet
- Aaron K. AragakiAAAaron K. Aragaki
- Peter HolmansPHPeter Holmans
- Lichuan YangLYLichuan Yang
- Carine ClerenCCCarine Cleren
- M. Flint BealMBM. Flint Beal
- Lesley JonesLJLesley Jones
- Charles KooperbergCKCharles Kooperberg
- James M. OlsonJOJames M. Olson
- Kevin R. JonesKJKevin R. Jones
Open Access
- 24 October 2007
- journal article
- research article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 27 (43) , 11758-11768
Abstract
Many pathways have been proposed as contributing to Huntington's disease (HD) pathogenesis, but generally thein vivoeffects of their perturbation have not been compared with reference data from human patients. Here we examine how accurately mechanistically motivated and genetic HD models recapitulate the striatal gene expression phenotype of human HD. The representative genetic model was the R6/2 transgenic mouse, which expresses a fragment of the huntingtin protein containing a long CAG repeat. Pathogenic mechanisms examined include mitochondrial dysfunction; profiled in 3-nitropropionic acid-treated rats, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice, andPGC-1α knock-out mice; and depletion of brain-derived neurotrophic factor (BDNF) using heterozygous and forebrain-specific BDNF-knock-out mice (BDNFHET,Emx-BDNFKO). Based on striatal gene expression, we find the BDNF models, both heterozygous and homozygous knock-outs, to be more like human HD than the other HD models. This implicates reduced trophic support as a major pathway contributing to striatal degeneration in HD. Because the majority of striatal BDNF is synthesized by cortical neurons, the data also imply that cortical dysfunction contributes to HD's hallmark effects on the basal ganglia. Finally, the results suggest that striatal lesions caused by mitochondrial toxins may arise via pathways different from those that drive neurodegeneration in HD. Based on these findings, we present a testable model of HD pathogenesis that, unlike most models, begins to account for regional specificity in human HD and the absence of such specificity in genetic mouse models of HD.Keywords
This publication has 47 references indexed in Scilit:
- Huntingtin Interacting Proteins Are Genetic Modifiers of NeurodegenerationPLOS Genetics, 2007
- Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's diseaseMolecular Neurodegeneration, 2007
- Conservation of Regional Gene Expression in Mouse and Human BrainPLOS Genetics, 2007
- Regional and cellular gene expression changes in human Huntington's disease brainHuman Molecular Genetics, 2006
- Juvenile Huntington's disease: Does a dosage-effect pathogenic mechanism differ from the classical adult disease?Mechanisms of Ageing and Development, 2006
- Temporal evolution of mouse striatal gene expression following MPTP injuryNeurobiology of Aging, 2005
- Brain-Derived Neurotrophic Factor Regulates the Onset and Severity of Motor Dysfunction Associated with Enkephalinergic Neuronal Degeneration in Huntington's DiseaseJournal of Neuroscience, 2004
- Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genesNature Genetics, 2003
- Wild-Type and Mutant Huntingtins Function in Vesicle Trafficking in the Secretory and Endocytic PathwaysExperimental Neurology, 1998
- Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic MiceCell, 1996